You are here: Welcome to the MPKB » Welcome to the MPKB » Diseases » Graves' disease
Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
home:diseases:graves [01.04.2019] – [Testing] sallieqhome:diseases:graves [09.14.2022] (current) – external edit 127.0.0.1
Line 9: Line 9:
 ===== Introduction ===== ===== Introduction =====
  
-[[http://www.mayoclinic.org/diseases-conditions/graves-disease/basics/definition/con-20025811|Mayo Clinic overview]]+[[https://www.mayoclinic.org/diseases-conditions/graves-disease/basics/definition/con-20025811|Mayo Clinic overview]]
  
 ==== Thyroid markers ==== ==== Thyroid markers ====
Line 23: Line 23:
  
  
-//Nanba, T., M. Watanabe, et al. (2009).// "Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease." . (({{pubmed>long:19415997}}))+//Nanba, T., M. Watanabe, et al. (2009).// "Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease." . (({{pmid>long:19415997}}))
 ===== Evidence of infectious cause ===== ===== Evidence of infectious cause =====
  
Line 29: Line 29:
 "AUTOIMMUNE DISEASE ASSOCIATED WITH IRIS Graves Disease Several different autoimmune processes have been described in patients initiating ART, although a clear association with IRIS has yet to be defined for many. It is widely accepted that Graves disease occurring after ART initiation is a manifestation of IRIS. This occurs late in the course of immune restoration, with a median time to onset after ART initiation of 21 months. In one study the median CD4 count before initiation of therapy in patients who developed Graves disease was 10 cells/mm, indicating severe immunodeficiency at the time of ART initiation in this population." "AUTOIMMUNE DISEASE ASSOCIATED WITH IRIS Graves Disease Several different autoimmune processes have been described in patients initiating ART, although a clear association with IRIS has yet to be defined for many. It is widely accepted that Graves disease occurring after ART initiation is a manifestation of IRIS. This occurs late in the course of immune restoration, with a median time to onset after ART initiation of 21 months. In one study the median CD4 count before initiation of therapy in patients who developed Graves disease was 10 cells/mm, indicating severe immunodeficiency at the time of ART initiation in this population."
  
-<blockquote> Distinguishing between manifestations of IRIS and active infection is of paramount importance and poses a diagnostic challenge to the provider in the acute care setting. Presentations of IRIS are often atypical for the precipitating pathogen, and novel presentations are likely. Of the diseases associated with IRIS, mycobacteria and cryptococcal infections are commonly encountered, as are dermatologic symptoms in general.   (({{pubmed>long:20413021}})) </blockquote>+<blockquote> Distinguishing between manifestations of IRIS and active infection is of paramount importance and poses a diagnostic challenge to the provider in the acute care setting. Presentations of IRIS are often atypical for the precipitating pathogen, and novel presentations are likely. Of the diseases associated with IRIS, mycobacteria and cryptococcal infections are commonly encountered, as are dermatologic symptoms in general.   (({{pmid>long:20413021}})) </blockquote>
  
 ===== Patient posted ===== ===== Patient posted =====
Line 52: Line 52:
  
 //Hogan//</blockquote> //Hogan//</blockquote>
 +
 +
 +Also test mineral status, as Selenium and Iodine are essential for thyroid hormone synthesis and function.(({{pmid>long:26088475}})) 
  
 {{tag>diseases }} {{tag>diseases }}
Line 59: Line 62:
  
  
 +<nodisp>
 ===== Notes and comments ===== ===== Notes and comments =====
  
Line 70: Line 74:
  
  
-===== References =====+===== References =====</nodisp> 
home/diseases/graves.1546641439.txt.gz · Last modified: by sallieq
© 2015, Autoimmunity Research Foundation. All Rights Reserved.